First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive HR+/HER2-advanced breast cancer (ABC): a subgroup analysis of RIGHT Choice by intrinsic subtype & gene & signature expression

Lu Y., Hsu C., Mahidin E. I. B. M., Gupta S., Goekmen E., Artamonova E., ...More

CLINICAL CANCER RESEARCH, vol.31, no.12, 2025 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 31 Issue: 12
  • Publication Date: 2025
  • Doi Number: 10.1158/1557-3265.sabcs24-ps2-06
  • Journal Name: CLINICAL CANCER RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No